Gensaic Names Nathan Higginson-Scott, as Chief R&D Officer
28 Jan 2026 //
BUSINESSWIRE
Gensaic, Novo Nordisk Partner on Next-Gen Precision Therapies
03 Mar 2025 //
BUSINESSWIRE
Gensaic Receives Funding From the CF Foundation to Develop a Gene Therapy
09 Jan 2023 //
BUSINESSWIRE

Market Place
Sourcing Support